Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Times Tennessee.
Press releases published on April 28, 2025

LayerX Security Extends Series A Funding to $37M to Power Next-Gen Enterprise Browser Security, Challenges SSE Solutions and Enterprise Browsers
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LayerX, the leading Secure Enterprise Browser Extension, today announced it has raised an $11 million extension to its $26 million Series A funding round, bringing the total amount raised to $45 million. The …

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug
SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent …

Plug Power Signs $525 Million Secured Credit Facility with Yorkville Advisors and Reports Strong Preliminary Q1 2025 Results
SLINGERLANDS, N.Y., April 28, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, today announced it has signed a definitive agreement for a secured debt facility and achieved key operational and …

The Secret Tool Hair Loss Providers Use to Treat Their Own Hair Loss?
CLEVELAND, April 28, 2025 (GLOBE NEWSWIRE) -- The Secret Is Out — And It’s Surprisingly Simple When it comes to hair loss, you’d think the professionals who spend their lives treating it have all the answers. Access to the best clinics, the latest …

Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™
New patents provide additional composition of matter and methods of use claims, strengthening the protection for liquid oral taste-masked reformulation, LIKMEZ New subject matter listed in the U.S. Food and Drug Administration’s (“FDA”) Orange Book HALIFAX …

Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …

Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST
– Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure – – Combination of ziftomenib and imatinib shows robust and durable antitumor activity in imatinib-sensitive and …

Nano Dimension to Host 2024 Financial Results and 2025 Outlook Conference Call
Call to Be Held Wednesday, April 30 at 4:30 PM EST Waltham, Massachusetts, April 28, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today announced it will host …

Montage Gold Announces Graduation to the Toronto Stock Exchange
VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- Montage Gold Corp. (“Montage” or the “Company”) (TSXV: MAU, OTCQX: MAUTF) is pleased to announce that it has received final approval from the Toronto Stock Exchange ("TSX") for the listing of …

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development
Overall survival and clinical benefit in Phase 2 continue to outperform historical benchmarks, including very heavily pretreated patients Clinical benefit observed in 83% of evaluable patient sub-group treated with the phase 3 formulation Improved new Bria …

TikTok’s Favorite Foodie Kate Norkeliunas Teams Up with MGA’s Miniverse™ to Launch Make It Mini From Scratch™, The Collectible You Make Yourself
LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- The original miniature brand where DIY meets collectability, MGA’s Miniverse™, is proud to debut its newest collection, MGA’s Miniverse™ Make It Mini From Scratch™. With more than 4 billion views of # …

NANO Nuclear Announces Full Dismissal of Nevada Lawsuit
New York, N.Y., April 28, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that on …

Chengdu Will Mark 100-day Countdown to TWG 2025 Chengdu
CHENGDU, China, April 28, 2025 (GLOBE NEWSWIRE) -- On April 29, on the eve of International Workers' Day, the countdown to the TWG 2025 Chengdu will reach the critical 100-day mark. Chengdu, the host city, is welcoming the upcoming The World Games 2025 …

EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Global Partnership and First-Ever 5K Run Sponsorship
WASHINGTON, April 28, 2025 (GLOBE NEWSWIRE) -- As the world marks World Malaria Day 2025 under the theme “Malaria Ends With Us: Reinvest, Reimagine, Reignite,” EBC Financial Group (EBC) is renewing its global partnership with the United Nations Foundation’ …

Microchip Expands Connectivity, Storage and Compute Portfolios to Meet the Growing Demands of AI Data Center Applications
CHANDLER, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- The rapid growth of artificial intelligence (AI) is transforming data centers, creating an unprecedented demand for high-performance, secure, reliable and innovative solutions. Microchip Technology ( …

Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025
PETAH TIKVA, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced management’s participation in the 20th Annual …

Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
Approval of Lynozyfic is based on data showing deep and durable responses in relapsed/refractory multiple myeloma Lynozyfic will provide a new option with convenient dosing and administration to patients who face cycles of relapse and remission TARRYTOWN, …

Biomed Valley Discoveries Announces First Patient Dosed in Phase 1/2 Combination Study of Ulixertinib with Ruxolitinib (Jakafi®) in Patients with Myelofibrosis
-- Dual targeting of JAK 1/2 (ruxolitinib) and ERK 1/2 (ulixertinib) may represent a novel treatment approach for myelofibrosis and possibly other myeloproliferative neoplasms KANSAS CITY, Mo., April 28, 2025 (GLOBE NEWSWIRE) -- Biomed Valley Discoveries ( …

Hudbay’s Eugene Lei wins Globe and Mail’s Report on Business 2025 Best Executive Award
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that Eugene Lei, Chief Financial Officer at Hudbay, has been recognized as a winner of the Globe and Mail’s Report on …

Kandi Technologies Reports 2024 Financial Results
Revenue Of $127.6M up 3.2% YoY, Supported by Expanded Product Reach And Improved Geographic Balance Electric Off-Road Vehicle Revenue Rose 8.9% YoY, Reinforcing Core Segment Leadership Enhanced Supply Chain Flexibility with Taiwan Upgrades, While …